Adipose stem cells: Biology, safety, regulation, and regenerative potential

Clinics in Plastic Surgery

Volumn 42, Issue 2, 2015, Pages 169-179

  Minteer, Danielle M ^a   Marra, Kacey G ^a,b,c   Rubin, J Peter ^a,b,c  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adipose; Adipose derived stem cells; Clinical translation; Mesenchymal stem cells; Regenerative medicine; Stem cell safety; Stromal vascular fraction; Tissue engineering

Indexed keywords

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; CELL INTERACTION; CELL ISOLATION; CELL REGENERATION; FAT GRAFTING; FOOD AND DRUG ADMINISTRATION; HEALING; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; REGENERATIVE MEDICINE; REVIEW; SAFETY; TISSUE ENGINEERING; TISSUE GRAFT; TISSUE REGENERATION; TUMOR CELL; ADIPOCYTE; CYTOLOGY; PROCEDURES; STEM CELL; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ADIPOCYTES; ADIPOSE TISSUE; HUMANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84925859936     PISSN: 00941298     EISSN: 15580504     Source Type: Journal    
DOI: 10.1016/j.cps.2014.12.007     Document Type: Review

References (117)

1. Ando H., Yanagihara H., Hayashi Y., et al. Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology 2005, 146(12):5631-5636.
2. Li H., Zimmerlin L., Marra K.G., et al. Adipogenic potential of adipose stem cell subpopulations. Plast Reconstr Surg 2011, 128(3):663-672.
3. Minteer D., Marra K.G., Peter Rubin J. Adipose-derived mesenchymal stem cells: biology and potential applications. Mesenchymal stem cells-basics and clinical application I 2013, 59-71. Springer, Berlin, Heidelberg.
4. Rubin J.P., Marra K.G. Soft tissue reconstruction. Methods Mol Biol 2011, 702:395-400.
5. Zimmerlin L., Donnenberg V.S., Pfeifer M.E., et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry A 2010, 77(1):22-30.
6. Dardick I., Poznanski W.J., Waheed I., et al. Ultrastructural observations on differentiating human preadipocytes cultured invitro. Tissue Cell 1976, 8(3):561-571.
7. Emre Aksu A., Rubin J.P., Dudas J.R., et al. Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells. Ann Plast Surg 2008, 60(3):306-320.
8. Green H., Kehinde O. An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion. Cell 1975, 5(1):19-27.
9. Hollenberg C.H., Vost A. Regulation of DNA synthesis in fat cells and stromal elements from rat adipose tissue. JClin Invest 1968, 47:2485-2498.
10. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7(2):211-228.
11. Stiles J.W., Francendese A.A., Masoro E.J. Influence of age on size and number of fat cells in the epididymal depot. Am J Physiol 1975, 229(6):1561-1568.
12. Mehlhorn A.T., Niemeyer P., Kaiser S., et al. Differential expression pattern of extracellular matrix molecules during chondrogenesis of mesenchymal stem cells from bone marrow and adipose tissue. Tissue Eng 2006, 12(10):2853-2862.
13. Planat-Bénard V., Menard C., André C., et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004, 94:223-229.
14. Brayfield C.A., Marra K.G., Rubin J.P. Adipose stem cells for soft tissue regeneration. Handchir Mikrochir Plast Chir 2010, 42:124-128.
15. Bunnell B.A., Estes B.T., Guilak F., et al. Differentiation of adipose stem cells. Methods Mol Biol 2008, 456:155-171.
16. Frye C.A., Patrick C.W. Three-dimensional adipose tissue model using low shear bioreactor. InVitro Cell Dev Biol Anim 2006, 42(5):109-114.
17. Gerlach J.C., Lin Y.C., Brayfield C.A., et al. Adipogenesis of human adipose-derived stem cells within three-dimensional hollow fiber-based bioreactors. Tissue Eng 2012, 18(1):54-61.
18. Zuk P.A., Zhu M., Ashjian P., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13(12):4279-4295.
19. Miyahara Y., Nagaya N., Kataoka K., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12(4):459-465.
20. Strem B.M., Hicok K.C., Zhu M., et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005, 54(3):132-141.
21. Choi Y.S., Cha S.M., Lee Y.Y., et al. Adipogenic differentiation of adipose tissue derived adult stem cells in nude mouse. Biochem Biophys Res Commun 2006, 345(2):631-637.
22. Kimura Y., Ozeki M., Inamoto T., et al. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 2003, 24:2513-2521.
23. Lee J.H., Kemp D.M. Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. Biochem Biophys Res Commun 2006, 341(3):882-888.
24. Rodriguez L.V., Alfonso Z.C., Zhang R., et al. Clonogenic multipotent stem cells in human adipose tissue differentiate in muscle cells. Proc Natl Acad Sci U S A 2006, 103(32):12167-12172.
25. Gaustad K.G., Boquest A.C., Anderson B.E., et al. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun 2004, 314(2):420-427.
26. Miranville A., Heeschen C., Sengenés C., et al. Development of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004, 110:349-355.
27. Lin Y., Chen X., Yan Z., et al. Multilineage differentiation of adipose-derived stromal cells from GFP transgenic mice. Mol Cell Biochem 2006, 285(1-2):69-78.
28. Ning H., Lin G., Lue T.F., et al. Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation 2006, 74(9-10):510-518.
29. Cowan C.M., Aalami O.O., Shi Y.Y., et al. Bone morphogenetic protein 2 and retinoic acid accelerate invivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 2005, 11(3-4):645-658.
30. Kang S.K., Lee D.H., Bae Y.C., et al. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003, 183(2):355-366.
31. Yoshimura K., Sato K., Aoi N., et al. Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells. Dermatol Surg 2008, 34:1178.
32. Yoshimura K., Sato K., Aoi N., et al. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 2008, 32:48. [discussion: 6-7].
33. Matsumoto D., Sato K., Gonda K., et al. Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng 2006, 12:3375.
34. Moseley T.A., Zhu M., Hedrick M.H. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 2006, 118:121S.
35. Kølle S.F., Fischer-Nielsen A., Mathiasen A.B., et al. Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet 2013, 382(9898):1113-1120.
36. Rubin J.P., Marra K.G. Commentary. Cell-assisted lipotransfer (CAL). Aesthet Surg J 2010, 30:82.
37. Donnenberg V.S., Zimmerlin L., Rubin J.P., et al. Regenerative therapy after cancer: what are the risks?. Tissue Eng Part B Rev 2010, 16(6):567-575.
38. Zimmerlin L., Park T.S., Zambidis E.T., et al. Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie 2013, 95(12):2235-2245.
39. Zimmerlin L., Donnenberg A.D., Rubin J.P., et al. Regenerative therapy and cancer: invitro and invivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011, 17:93-106.
40. Rene Gonzalez R., Watters A., Xu Y., et al. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Breast Cancer Res 2009, 11:R36.
41. Baldo A., Sniderman A.D., St.Luce S., et al. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. JClin Invest 1993, 92:1543.
42. Neuber F. Fettransplantation. Verh Dtsch Ges Chir 22(1893):66.
43. Czerny M. Reconstruction of the breast with a lipoma. Chir Kongr Verh 2 (1895): 216.
44. Zimmerlin L., Rubin J.P., Pfeifer M.E., et al. Human adipose stromal vascular cell delivery in a fibrin spray. Cytotherapy 2012, 15:102-108.
45. Pinilla S., Alt E., Abdul Khalek F.J., et al. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett 2009, 284:80.
46. Kucerova L., Matuskova M., Hlubinova K., et al. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 2010, 9:129.
47. Almog N., Ma L., Raychowdhury R., et al. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res 2009, 69:836.
48. Donnenberg V.S., Luketich J.D., Landreneau R.J., et al. Tumorigenic epithelial stem cells and their normal counterparts. Ernst Schering Found Symp Proc 2006, 5:245.
49. Abraham B.K., Fritz P., McClellan M., et al. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 2005, 11:1154.
50. Sheridan C., Kishimoto H., Fuchs R.K., et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006, 8:R59.
51. Min S.Y., Kim H.Y., Jung S.Y., et al. Oncological safety and quality of life associated with mastectomy and immediate breast construction with a latissimus dorsi myocutaneous flap. Breast J 2010, 16:356.
52. Delay E., Garson S., Tousson G., et al. Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years. Aesthet Surg J 2009, 29:360.
53. Petit J.Y., Botteri E., Lohsiriwat V., et al. Locoregional recurrence risk after lipofilling in breast cancer patients. Ann Oncol 2012, 23(3):582-588.
54. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). 21 CFR 1271. 2007.
55. Naghshineh N., Brown S., Cederna P.S., et al. Demystifying the US Food and Drug Administration: understanding regulatory pathways. Plast Reconstr Surg 2014, 134(3):559-569.
56. Schipper B.M., Marra K.G., Zhang W., et al. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg 2008, 60(5):538-544.
57. Minteer D.M., Gerlach J.C., Marra K.G. Bioreactors addressing diabetes mellitus. JDiabetes Sci Technol 2014, 8(6):1227-1232.
58. Patrick C., Uthamanthil R., Beahm E., et al. Animal models for adipose tissue engineering. Tissue Eng Part B Rev 2008, 14:167-178.
59. Clavijo-Alvarez J.A., Rubin J.P., Bennett J., et al. Anovel perfluoroelastomer seeded with adipose-derived stem cells for soft-tissue repair. Plast Reconstr Surg 2006, 118:1132.
60. Thesleff T., Lehtimaki K., Niskakangas T., et al. Cranioplasty with adipose-derived stem cells and biomaterial: a novel method for cranial reconstruction. Neurosurgery 2011, 68:1535-1540.
61. Mesimaki K., Lindroos B., Tornwall J., et al. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg 2009, 38:201-209.
62. Lee K., Kim H., Kim J.M., et al. Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function. JCell Mol Med 2011, 15:2082-2094.
63. Levi B., James A.W., Nelson E.R., et al. Acute skeletal injury is necessary for human adipose-derived stromal cell-mediated calvarial regeneration. Plast Reconstr Surg 2011, 127:1118-1129.
64. Levi B., James A.W., Nelson E.R., et al. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One 2010, 5:E11177.
65. Cowan C.M., Shi Y.Y., Aalami O.O., et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004, 22:560-567. Landmark study documenting the utility of ASCs for the repair of a murine cranial bone defects.
66. Lendeckel S., Jodicke A., Christophis P., et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. JCraniomaxillofac Surg 2004, 32:370-373.
67. Bai X., Alt E. Myocardial regeneration potential of adipose tissue-derived stem cells. Biochem Biophys Res Commun 2010, 401:321-326.
68. Mazo M., Gavira J.J., Pelacho B., et al. Adipose-derived stem cells for myocardial infarction. JCardiovasc Transl Res 2011, 4:145-153.
69. Bai X., Yan Y., Song Y.H., et al. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J 2010, 31:489-501.
70. Bai X., Yan Y., Coleman M., et al. Tracking long-term survival of intramyocardially delivered human adipose tissue-derived stem cells using bioluminescence imaging. Mol Imaging Biol 2011, 13:633-645.
71. Ii M., Horii M., Yokoyama A., et al. Synergistic effect of adipose-derived stem cell therapy and bone marrow progenitor recruitment in ischemic heart. Lab Invest 2010, 91(4):539-552.
72. Bayes-Genis A., Soler-Botija C., Farre J., et al. Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. JMol Cell Cardiol 2010, 49:771-780.
73. Gaebel R., Furlani D., Sorg H., et al. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One 2011, 6:E15652.
74. Alt E., Pinkernell K., Scharlau M., et al. Effect of freshly isolated autologous tissue resident stromal cells on cardiac function and perfusion following acute myocardial infarction. Int J Cardiol 2010, 144:26-35.
75. Fotuhi P., Song Y.H., Alt E. Electrophysiological consequence of adipose-derived stem cell transplantation in infarcted porcine myocardium. Europace 2007, 9:1218-1221.
76. Valina C., Pinkernell K., Song Y.H., et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007, 28:2667-2677.
77. Bel A., Planat-Bernard V., Saito A., et al. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 2010, 122:S118-S123.
78. Eto H., Suga H., Inoue K., et al. Adipose injury-associated factors mitigate hypoxia in ischemic tissues through activation of adipose-derived stem/progenitor/stromal cells and induction of angiogenesis. Am J Pathol 2011, 178:2322-2332.
79. Yang Y.C., Liu B.S., Shen C.C., et al. Transplantation of adipose tissue-derived stem cells for treatment of focal cerebral ischemia. Curr Neurovasc Res 2011, 8:1-13.
80. Lewis D.S., Soderstrom P.G. Invivo and invitro development of visceral adipose tissue in a nonhuman primate (Papio species). Metabolism 1993, 42:1277-1283.
81. Zuk P.A. Viral transduction of adipose-derived stem cells. Methods Mol Biol 2011, 702:345-357.
82. Choi E.W., Shin I.S., Lee H.W., et al. Transplantation of CTLA4Ig gene-transduced adipose tissue-derived mesenchymal stem cells reduces inflammatory immune response and improves Th1/Th2 balance in experimental autoimmune thyroiditis. JGene Med 2011, 13:3-16.
83. McIntosh K., Zvonic S., Garrett S., et al. The immunogenicity of human adipose derived cells: temporal changes invitro. Stem Cells 2006, 24:1245-1253.
84. Puissant B., Barreau C., Bourin P., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005, 129:118-129.
85. Riordan N.H., Ichim T.E., Min W.P., et al. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. JTransl Med 2009, 7:29.
86. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation invitro and prolong skin graft survival invivo. Exp Hematol 2002, 30:42-48.
87. Ivanova-Todorova E., Bochev I., Mourdjeva M., et al. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared with bone marrow-derived mesenchymal stem cells. Immunol Lett 2009, 126:37-42.
88. DelaRosa O., Lombardo E., Beraza A., et al. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A 2009, 15:2795-2806.
89. Shi D., Liao L., Zhang B., et al. Human adipose tissue-derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1-mediated inhibition of NF-κB signaling. Exp Hematol 2011, 39:214-224.
90. Crop M.J., Baan C.C., Korevaar S.S., et al. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev 2010, 19:1843-1853.
91. Kronsteiner B., Wolbank S., Peterbauer A., et al. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev 2011, 20(12):2115-2126.
92. Technau A., Froelich K., Hagen R., et al. Adipose tissue-derived stem cells show both immunogenic and immunosuppressive properties after chondrogenic differentiation. Cytotherapy 2011, 13:310-317.
93. Calderon D., Planat-Benard V., Bellamy V., et al. Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells. JCell Mol Med 2011, 16(7):1544-1552.
94. Choi E.W., Shin I.S., Park S.Y., et al. Reversal of serological, immunological and histological dysfunction in systemic lupus erythematosus mice by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum 2012, 64(1):243-253.
95. Gonzalez M.A., Gonzalez-Rey E., Rico L., et al. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 2009, 60:1006-1019.
96. Gonzalez-Rey E., Gonzalez M.A., Varela N., et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T-cell responses and induce regulatory T cells invitro in rheumatoid arthritis. Ann Rheum Dis 2010, 69:241-248.
97. Gonzalez M.A., Gonzalez-Rey E., Rico L., et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009, 136:978-989.
98. Gonzalez-Rey E., Anderson P., Gonzalez M.A., et al. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 2009, 58:929-939.
99. Garcia-Olmo D., Garcia-Arranz M., Garcia L.G., et al. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int J Colorectal Dis 2003, 18:451-454.
100. Garcia-Olmo D., Garcia-Arranz M., Herreros D. Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease. Expert Opin Biol Ther 2008, 8:1417-1423.
101. Garcia-Olmo D., Garcia-Arranz M., Herreros D., et al. APhase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005, 48:1416-1423.
102. Garcia-Olmo D., Herreros D., Pascual I., et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009, 52:79-86.
103. Garcia-Olmo D., Herreros D., Pascual M., et al. Treatment of enterocutaneous fistula in Crohn's disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. Int J Colorectal Dis 2009, 24:27-30.
104. Constantin G., Marconi S., Rossi B., et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009, 27:2624-2635.
105. Kang H.M., Kim J., Park S., et al. Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells 2009, 27:1999-2008.
106. Chandra V., G S., Phadnis S., et al. Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells. Stem Cells 2009, 27:1941-1953.
107. Chandra V., Swetha G., Muthyala S., et al. Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PLoS One 2011, 6:E20615.
108. Ohmura Y., Tanemura M., Kawaguchi N., et al. Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice. Transplantation 2010, 90:1366-1373.
109. Fumimoto Y., Matsuyama A., Komoda H., et al. Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice. Tissue Eng Part C Methods 2009, 15:437-444.
110. Fang B., Song Y., Liao L., et al. Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant Proc 2007, 39:3358-3362.
111. NIH. Registry and results database of federally andprivately supported clinical trials conducted in the United States. 2014. Available at: Accessed December 15, 2014. http://www.clinicaltrials.gov.
112. Meirelles Lda S., Fontes A.M., Covas D.T., et al. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009, 20:419-427.
113. Gimble J.M., Bunnell B.A., Guilak F. Human adipose-derived cells: an update on the transition to clinical translation. Regen Med 2012, 7(2):225-235.
114. Sensebe L., Bourin P. Producing MSC according GMP: process and controls. Biomed Mater Eng 2008, 18:173-177.
115. Sensebe L., Bourin P., Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 2011, 22:19-26.
116. Bourin P., Gadelorge M., Peyrafitte J.A., et al. Mesenchymal progenitor cells: tissue origin, isolation and culture. Transfus Med Hemother 2008, 35:160-167.
117. Reed W., Noga S.J., Gee A.P., et al. Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies. Transfusion 2009, 49(4):786-796.